During investment forum Sochi 2015 the international company MERCK and the Russian copany NANOLEK have signed agreement of pharmaceutical production for curing diabetes of type II, hypertension and heart failure on the factory in Kirov region. MERCK localization investments are to become 10 mln euro to the end of 2016. According to the... More →
3-day 17th exhibition DenTech China ended on October 26th in Shanghai World Exhibition and Convention Centre (www.shexpocenter.com). This year there were more than 650 companies introducing their products at the exhibition space of 34 000 sq m. Among foreign exhibitors the biggest number of companies was from 3 national pavilions... More →
INMETRO's mandatory certification of needles and syringes commercialized in the country became effective on July 1st, 2013. The deadline for conformance of these materials ended last Monday (July 1st). The minimum requirements for product identity and quality were determined by ANVISA in 2011 in order to ensure the minimum standards for health... More →
Pharmstandard, a major Russian pharmaceuticals manufacturer, is considering selling its non-prescription drug business with the company's owners putting a price tag of $2.5 billion on the asset.
The sale of Pharmstandard's over-the-counter (OTC) medicines business is still in the early stages, Bloomberg said, citing sources. It is also known... More →
The Russian medical regulatory agency Roszdravnadzor is urging medical device manufacturers planning to do business within the country’s borders to familiarize themselves with new product registration requirements. The updated regulations, which came into effect January 1, 2013, target both on-sale medical devices as well as those currently... More →
According to our latest report, entitled “OTC market in CIS countries 2012. Comparative analysis and development forecasts for 2012-2014”, the OTC market in the CIS countries1 was worth €7.4bn in 2011, after a year-on-year increase of more than 10%. Between 2012 and 2014 the market is expected to develop at a CAGR... More →
SAO PAULO, Oct 8 (Reuters) - With a $4.9 billion takeover of Brazil's biggest healthcare provider, UnitedHealth Group appears to have snatched the crown jewel in a market with plenty of promise but formidable barriers to entry for any foreign rivals looking to follow suit.
UnitedHealth's plan to acquire a 90 percent stake in Amil Participacoes... More →
SHANGHAI (Oct. 2, 2012) -- Seeing growing interest from global medical device companies in manufacturing in China, Singaporean firm Forefront Medical Technology is investing S$10 million (51.3 million Chinese yuan) in a plastics molding and extrusion facility in East China to tap into the market.
The facility, in Changzhou, Jiangsu province,... More →
China seems destined to become the world’s biggest pharmaceutical market; however, whether the profits multinational corporations (MNCs) realize will be similarly attractive remains very much in doubt.
In 2011, the top ten MNC pharmaceuticals selling into China generated well over $20 billion in sales within China. Growth rates for these... More →